Gkaliagkousi E - Search Results

1

Platelet activation in essential hypertension: implications for antiplatelet treatment.

Gkaliagkousi E, Passacquale G, Douma S, Zamboulis C, Ferro A. Gkaliagkousi E, et al. Am J Hypertens. 2010 Mar;23(3):229-36. doi: 10.1038/ajh.2009.247. Epub 2010 Jan 21. Am J Hypertens. 2010. PMID: 20094035

2

beta-Actin regulates platelet nitric oxide synthase 3 activity through interaction with heat shock protein 90.

Ji Y, Ferracci G, Warley A, Ward M, Leung KY, Samsuddin S, Lévêque C, Queen L, Reebye V, Pal P, Gkaliagkousi E, Seager M, Ferro A. Ji Y, et al. Among authors: gkaliagkousi e. Proc Natl Acad Sci U S A. 2007 May 22;104(21):8839-44. doi: 10.1073/pnas.0611416104. Epub 2007 May 14. Proc Natl Acad Sci U S A. 2007. PMID: 17502619 Free PMC article.

3

Age decreases nitric oxide synthesis and responsiveness in human platelets and increases formation of monocyte-platelet aggregates.

Goubareva I, Gkaliagkousi E, Shah A, Queen L, Ritter J, Ferro A. Goubareva I, et al. Among authors: gkaliagkousi e. Cardiovasc Res. 2007 Sep 1;75(4):793-802. doi: 10.1016/j.cardiores.2007.05.021. Epub 2007 May 24. Cardiovasc Res. 2007. PMID: 17572401

4

Platelet-derived nitric oxide signaling and regulation.

Gkaliagkousi E, Ritter J, Ferro A. Gkaliagkousi E, et al. Circ Res. 2007 Sep 28;101(7):654-62. doi: 10.1161/CIRCRESAHA.107.158410. Circ Res. 2007. PMID: 17901370 Review.

5

Decreased platelet nitric oxide contributes to increased circulating monocyte-platelet aggregates in hypertension.

Gkaliagkousi E, Corrigall V, Becker S, de Winter P, Shah A, Zamboulis C, Ritter J, Ferro A. Gkaliagkousi E, et al. Eur Heart J. 2009 Dec;30(24):3048-54. doi: 10.1093/eurheartj/ehp330. Eur Heart J. 2009. PMID: 19687162

6

Nitric oxide dysfunction in vascular endothelium and platelets: role in essential hypertension.

Gkaliagkousi E, Douma S, Zamboulis C, Ferro A. Gkaliagkousi E, et al. J Hypertens. 2009 Dec;27(12):2310-20. doi: 10.1097/HJH.0b013e328330e89a. J Hypertens. 2009. PMID: 19838132 Review.

7

Endothelial function and arterial compliance are not impaired in subjects with heart failure of non-ischemic origin.

Shah A, Gkaliagkousi E, Ritter JM, Ferro A. Shah A, et al. Among authors: gkaliagkousi e. J Card Fail. 2010 Feb;16(2):114-20. doi: 10.1016/j.cardfail.2009.10.019. Epub 2009 Nov 14. J Card Fail. 2010. PMID: 20142022

8

Nitric oxide signalling in the regulation of cardiovascular and platelet function.

Gkaliagkousi E, Ferro A. Gkaliagkousi E, et al. Front Biosci (Landmark Ed). 2011 Jan 1;16(5):1873-97. doi: 10.2741/3828. Front Biosci (Landmark Ed). 2011. PMID: 21196271 Free article. Review.

9

Platelet nitric oxide signalling in heart failure: role of oxidative stress.

Shah A, Passacquale G, Gkaliagkousi E, Ritter J, Ferro A. Shah A, et al. Among authors: gkaliagkousi e. Cardiovasc Res. 2011 Sep 1;91(4):625-31. doi: 10.1093/cvr/cvr115. Epub 2011 Apr 18. Cardiovasc Res. 2011. PMID: 21502370

10

Surgical management of primary aldosteronism. not everything that shines is gold.

Douma S, Petidis K, Kamparoudis A, Gkaliagkousi E, Anyfanti P, Doumas M, Triantafyllou A, Lazaridis N, Gerasimidis T, Zamboulis C. Douma S, et al. Among authors: gkaliagkousi e. Clin Exp Hypertens. 2012;34(1):53-6. doi: 10.3109/10641963.2011.618204. Epub 2011 Oct 18. Clin Exp Hypertens. 2012. PMID: 22007678 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

136 results

Search Page

Filters